Compared with other antidiabetic medications, semaglutide was linked to a significantly lower risk of opioid overdose in ...

Doctors might be able to use a new scoring system to avoid unnecessary surgery to prevent strokes, a new study shows.

Having this information, especially for borrowers with a credit score similar to yours, gives you an idea of what rate to expect and a benchmark for comparing loan offers. The auto loan interest ...

There’s limited scientific evidence directly linking semaglutide use to vitamin B12 deficiency or recommending routine vitamin B12 supplementation for people taking semaglutide. Semaglutide is ...

Mumford & Sons return to the top 10 on Billboard’s Top Album Sales chart, as the band’s first album in over six years, Rushmere, debuts at No. 3 on the April 12-dated list. It’s the sixth ...

Official Trending Chart: Ed Sheeran, Sleep Token, Miley Cyrus and more score rising UK hits Ed is still on track for this week's highest new entry, while UK rock sensations Sleep Token approach a ...

We started with 68 teams in the NCAA Tournament bracket just a few weeks ago and, just like that, we are down to two teams and just one game left to decide the 2025 NCAA Tournament championship.

AdvaMed and nine other healthcare organizations continue to pressure the White House to exempt medical devices and critical supplies from the Trump administration’s tariff policies. AdvaMed, one of ...

Rybelsus (semaglutide) is an oral medication used in combination with exercise and a healthy diet to help treat type 2 diabetes. It’s best taken on an empty stomach but isn’t known to interact ...

The Darkness’ eighth studio album, ninth chart entry and fifth Top 10 set, Dreams On Toast was released in an abundance of variants – eight CD, six cassette and 13 vinyl – which help it to ...

By Thomas Smith Alex Warren has continued his dominant streak at the summit of the U.K. Singles Chart for a third consecutive week with breakout hit “Ordinary” (Apr. 4). The US singer ...

1 Revised MACE-5 occurred in 88 (0.94%) of the 9,321 patients in the semaglutide 2.4 mg group and 288 (1.54%) of 18,642 patients in the non-user group. 1 SCORE results were consistent across a variety ...